137-26-8

137-26-8结构式
137-26-8结构式
  • 常用中文名:二硫化四甲基秋兰姆
  • 常用英文名:Thiram
  • CAS号:137-26-8
  • 分子式:C6H12N2S4
  • 分子量:240.433
  • 相关类别: 化学农药原药 杀菌剂 有机硫杀菌剂
  • 发布时间:2018-07-10 16:36:40
  • 更新时间:2024-01-02 12:08:17
  • 【用途一】
    用作天然胶、合成胶及胶乳的超促进剂
    【用途二】
    用于制造电缆、电线、轮胎等橡胶制品
    【用途三】
    用作天然胶、顺丁胶、丁苯胶、异戊胶的后效性促进剂
    【用途四】
    用于水稻、小麦、烟草、甜菜、葡萄等多种作物病虫害防治,可用于拌种、土壤处理
    【用途五】
    属广谱的保护性杀菌剂,残效期达7d左右。主要用于处理种子和土壤,防治禾谷类作物白粉病、黑穗病、稻秧苗立枯病,也可用于一些果树、蔬菜病害。如用50%可湿性粉剂500g拌种,可防治稻瘟病,稻胡麻叶斑病,大麦、小麦黑穗病。
    【用途六】
    该品作为农药通常称为福美双,主要用于处理种子和土壤,防治禾谷类白粉病、黑穗病及蔬菜病害。该品作为天然胶、合成胶及胶乳的超促进剂,通常称促进剂TMTD,是秋兰姆硫化促进剂的代表,占同类产品总量的85%。作为天然胶、二烯类合成胶、Ⅱ、R、EPDM的超级促进剂,是利用率最高的一种。硫化促进力非常强,但无氧化锌存在时,则完全不硫化。

化源商城直购

中文名 福美双
英文名 Thiram
中文别名 四甲基秋兰姆二硫化物
二硫化四甲基秋兰姆(TMTD)
二硫化双(硫羰基二甲胺: N,N-四甲基二硫双硫羰胺
促进剂TMTD
橡胶促进剂 TMTD
二硫化四甲基秋兰
二硫化双(硫羰基二甲胺)
二硫化四甲基秋兰姆
福美
英文别名 tetramethylthioperoxydicarbonic diamide ([[(CH3)2N]C(S)]2S2)
anles
Thiuramyl
TMTDS
Tyradin
TNTD
TMTD
[Disulfanediylbis(carbonothioylnitrilo)]tétraméthane
Bis(dimethylthiocarbamyl) disulfide
MFCD00008325
Basultra
Nomersan
1N1&YUS&SSYUS&N1&1
Thiurad
Thylate
Tetramethylthiuram disulfide
Tulisan
EINECS 205-286-2
[Dithiobis(carbonothioylnitrilo)]tetramethane
N1,N1,N3,N3-tetramethyl-2-dithioperoxy-1,3-dithiodicarbonic diamide
Methane, [dithiobis(carbonothioylnitrilo)]tetrakis-
Tiuramyl
tmtc
Vanguard GF
[Disulfanediylbis(carbonothioylnitrilo)]tetramethane
tm-95
Thiuram (Thiram)
Tetramethylthiouram Disulfide
[Disulfanediylbis(carbonothioylnitrilo)]tetramethan
Thiram
aules
tigam
Heryl
Methane, 1,1',1'',1'''-[dithiobis(carbonothioylnitrilo)]tetrakis-
Tuex
Betoxin
bis(dimethylthiocarbamoyl) disulfide
thiuram
Tuads
Bis[(dimethylamino)carbonothioyl] disulfide
密度 1.3±0.1 g/cm3
沸点 307.4±25.0 °C at 760 mmHg
熔点 156-158 °C(lit.)
分子式 C6H12N2S4
分子量 240.433
闪点 139.7±23.2 °C
精确质量 239.988327
PSA 121.26000
LogP 1.75
外观性状 白色至灰白色粉末
蒸汽压 0.0±0.7 mmHg at 25°C
折射率 1.678
储存条件

通风、阴凉的地方贮存,避免直射。

稳定性

1、溶于苯、丙酮、氯仿、二硫化碳,微溶于乙醇、乙醚及四氯化碳,不溶于水、稀碱和汽油。与水共热生成二甲胺和二硫化。
2、遇酸分解。工业品为白色或淡黄色粉末。对人的黏膜和皮肤有刺激作用,长期接触的人饮酒有过敏反应。

水溶解性 16.5 mg/L (20 ºC)
分子结构

1、 摩尔折射率:67.86

2、 摩尔体积(cm3/mol):179.9

3、 等张比容(90.2K):516.6

4、 表面张力(3.0 dyne/cm):67.8

5、 极化率(0.5 10-24cm3):26.90

计算化学

1.疏水参数计算参考值(XlogP):1.7

2.氢键供体数量:0

3.氢键受体数量:4

4.可旋转化学键数量:3

5.互变异构体数量:无

6.拓扑分子极性表面积121

7.重原子数量:12

8.表面电荷:0

9.复杂度:158

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

更多

1.性状:白色结晶粉末

2.相对密度:1.29

3.熔点(℃):155~156

4.溶解性:不溶于水,不溶于稀苛性碱、汽油、微溶于乙醇、乙醚,溶于苯、丙酮、氯仿、四氯化碳、二硫化碳、二氯乙烷。

第一部分:化学品名称
化学品中文名称: 四甲基二硫代秋兰姆;硫化促进剂TMTD
化学品英文名称: Tetramethylthiuram disulfide;Thiram
中文俗名或商品名:
Synonyms:
CAS No.: 137-26-8
分子式: C6H12N2S4
分子量: 240.44
第二部分:成分/组成信息
纯化学品混合物
化学品名称:四甲基二硫代秋兰姆;硫化促进剂TMTD
有害物成分 含量 CAS No.
四甲基二硫代秋兰姆 100 137-26-8
第三部分:危险性概述
危险性类别:
侵入途径: 吸入 食入 经皮吸收
健康危害: 对呼吸道、皮肤、胃肠道有明显刺激作用,可抑制白细胞生成,大剂量误服可损害中枢神经系统,心脏、肝脏和内分泌腺,吸入后可产生过敏性。急性中毒少见,中毒后可有头痛、多汗,心动过速,心律不齐,呕吐、呼吸困难、支气管炎,荨麻疹等。口服大剂量后有恶心、呕吐、腹痛、腹泻。严重时出现神经系统兴奋,最后转入抑制和呼吸中枢麻痹,可有肝肾损害,接触本品后可提高对酒的敏感度。长期接触,可引起职业性皮炎,神衰综合征,眼及上
环境危害:
燃爆危险: 本品可燃,具刺激性,具致敏性。
第四部分:急救措施
皮肤接触: 脱去污染的衣着,用流动清水冲洗。
眼睛接触: 立即翻开上下眼睑,用流动清水冲洗15分钟。就医。
吸入: 脱离现场至空气新鲜处。呼吸困难时给输氧。就医。
食入: 误服者给饮足量温水,催吐,就医。
第五部分:消防措施
危险特性: 遇明火、高热可燃。受热分解,放出氮、硫的氧化物等毒性气体。
有害燃烧产物: 一氧化碳、二氧化碳、硫化物、氧化氮。
灭火方法及灭火剂: 雾状水、二氧化碳、泡沫、砂土。
消防员的个体防护: 消防人员须佩戴防毒面具、穿全身消防服,在上风向灭火
禁止使用的灭火剂:
闪点(℃): 无资料
自燃温度(℃): 无资料
爆炸下限[%(V/V)]: 无资料
爆炸上限[%(V/V)]: 无资料
最小点火能(mJ):
爆燃点:
爆速:
最大燃爆压力(MPa):
建规火险分级:
第六部分:泄漏应急处理
应急处理: 戴好防毒面具和手套。避免扬尘,收集于干燥洁净有盖的容器中,运至废物处理场所。如大量泄漏,收集回收或无害处理后废弃。
第七部分:操作处置与储存
操作注意事项: 密闭操作,全面通风。操作人员必须经过专门培训,严格遵守操作规程。建议操作人员佩戴自吸过滤式防尘口罩,戴化学安全防护眼镜,穿防毒物渗透工作服,戴橡胶手套。远离火种、热源,工作场所严禁吸烟。使用防爆型的通风系统和设备。避免产生粉尘。避免与氧化剂接触。搬运时要轻装轻卸,防止包装及容器损坏。配备相应品种和数量的消防器材及泄漏应急处理设备。倒空的容器可能残留有害物。
储存注意事项: 储存于阴凉、通风的库房。远离火种、热源。应与氧化剂分开存放,切忌混储。配备相应品种和数量的消防器材。储区应备有合适的材料收容泄漏物。
第八部分:接触控制/个体防护
最高容许浓度: 中 国 MAC:未制订标准前苏联MAC:0.5mg/m3美国TLVTN: ACGIH 1mg/m3
监测方法:
工程控制: 生产过程密闭,全面通风。
呼吸系统防护: 空气中浓度超标时,应该佩戴防毒面具。
眼睛防护: 必要时戴化学安全防护眼镜。
身体防护: 穿工作服。
手防护: 戴防护手套。
其他防护: 工作后,淋浴更衣。注意个人清洁卫生。
第九部分:理化特性
外观与性状: 白色或灰白色、有特殊气味、结晶粉末。
pH:
熔点(℃): 146~148
沸点(℃):
相对密度(水=1): 1.29
相对蒸气密度(空气=1):
饱和蒸气压(kPa):
燃烧热(kJ/mol):
临界温度(℃):
临界压力(MPa):
辛醇/水分配系数的对数值:
闪点(℃): 无资料
引燃温度(℃): 无资料
爆炸上限%(V/V): 无资料
爆炸下限%(V/V): 无资料
分子式: C6H12N2S4
分子量: 240.44
蒸发速率:
粘性:
溶解性: 不溶于水,不溶于稀碱液、汽油,溶于乙醇、苯、氯仿、二硫化碳等。
主要用途: 在橡胶工业中用作硫化促进剂、农业上用作杀菌剂和杀虫剂,也可用作润滑油添加剂等。
第十部分:稳定性和反应活性
稳定性: 在常温常压下 稳定
禁配物: 强氧化剂。
避免接触的条件:
聚合危害: 不能出现
分解产物: 一氧化碳、二氧化碳、硫化物、氧化氮。
第十一部分:毒理学资料
急性毒性: 属低毒类 LD50:小鼠经口:1.25g/kg;大鼠经口:0.87g/kg,对人的致死量估计为0.8g/kg LC50:
急性中毒:
慢性中毒:
亚急性和慢性毒性:
刺激性:
致敏性:
致突变性:
致畸性:
致癌性:
第十二部分:生态学资料
生态毒理毒性:
生物降解性:
非生物降解性:
生物富集或生物积累性:
第十三部分:废弃处置
废弃物性质:
废弃处置方法: 处置前应参阅国家和地方有关法规。建议用焚烧法处置。焚烧炉排出的气体要通过洗涤器除去。
废弃注意事项:
第十四部分:运输信息
危险货物编号:
UN编号:
包装标志:
包装类别:
包装方法: 无资料
运输注意事项: 起运时包装要完整,装载应稳妥。运输过程中要确保容器不泄漏、不倒塌、不坠落、不损坏。严禁与氧化剂、食用化学品等混装混运。运输途中应防曝晒、雨淋,防高温。车辆运输完毕应进行彻底清扫。
RETCS号:
IMDG规则页码:
第十五部分:法规信息
国内化学品安全管理法规:
国际化学品安全管理法规:
第十六部分:其他信息
参考文献: 1.周国泰,化学危险品安全技术全书,化学工业出版社,1997 2.国家环保局有毒化学品管理办公室、北京化工研究院合编,化学品毒性法规环境数据手册,中国环境科学出版社.1992 3.Canadian Centre for Occupational Health and Safety,CHEMINFO Database.1998 4.Canadian Centre for Occupational Health and Safety, RTECS Database, 1989
填表时间: 年月日
填表部门:
数据审核单位:
修改说明:
其他信息: 3
MSDS修改日期: 年月日

毒理学数据:

1、急性毒性 口服-大鼠 LD50:560 毫克/公斤;口服-小鼠 LC50:1250 毫克/公斤。
2、刺激数据 眼睛-兔子 100 毫克/24小时 中度。
3、对呼吸道及皮肤有刺激作用。
大鼠急性经口LD50为780 ~ 865mg/kg。小鼠急性经口LC50为1500 ~2000mg /kg。LC50为4mg/L

生态学数据:

对水体稍有危害。

CHEMICAL IDENTIFICATION

RTECS NUMBER :
JO1400000
CHEMICAL NAME :
Disulfide, bis(dimethylthiocarbamoyl)
CAS REGISTRY NUMBER :
137-26-8
BEILSTEIN REFERENCE NO. :
1725821
LAST UPDATED :
199801
DATA ITEMS CITED :
109
MOLECULAR FORMULA :
C6-H12-N2-S4
MOLECULAR WEIGHT :
240.44
WISWESSER LINE NOTATION :
1N1&YUS&SSYUS&N1&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration into the eye
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
TCLo - Lowest published toxic concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Human
DOSE/DURATION :
30 ug/m3/5Y-I
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - conjunctive irritation Cardiac - other changes Lungs, Thorax, or Respiration - structural or functional change in trachea or bronchi
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
560 mg/kg
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - true cholinesterase
TYPE OF TEST :
LC50 - Lethal concentration, 50 percent kill
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
500 mg/m3/4H
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
5 gm/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
138 mg/kg
TOXIC EFFECTS :
Behavioral - changes in motor activity (specific assay) Nutritional and Gross Metabolic - body temperature decrease
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
646 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
740 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1250 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Skin and Appendages - hair
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
70 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1109 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
230 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Behavioral - analgesia
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
210 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
210 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Bird - chicken
DOSE/DURATION :
840 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Mammal - domestic
DOSE/DURATION :
225 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
400 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - wild bird species
DOSE/DURATION :
300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
450 mg/kg/90D-I
TOXIC EFFECTS :
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - multiple enzyme effects Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
406 mg/kg/14D-I
TOXIC EFFECTS :
Liver - other changes Blood - other changes Biochemical - Metabolism (Intermediary) - lipids including transport
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
350 mg/kg/7D-C
TOXIC EFFECTS :
Brain and Coverings - other degenerative changes Kidney, Ureter, Bladder - other changes Nutritional and Gross Metabolic - changes in metals, not otherwise specified
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
10920 mg/kg/2Y-C
TOXIC EFFECTS :
Behavioral - food intake (animal) Musculoskeletal - other changes Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
TCLo - Lowest published toxic concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
91 mg/m3/26W-I
TOXIC EFFECTS :
Cardiac - other changes
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1680 mg/kg/4W-C
TOXIC EFFECTS :
Blood - changes in erythrocyte (RBC) count Skin and Appendages - hair Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
29120 mg/kg/2Y-I
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - retinal changes (pigmentary depositions, retinitis, other) Blood - changes in erythrocyte (RBC) count Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
1120 mg/kg/4W-I
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - retinal changes (pigmentary depositions, retinitis, other) Gastrointestinal - nausea or vomiting Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
1520 mg/kg/15W-I
TOXIC EFFECTS :
Vascular - BP lowering not characterized in autonomic section Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other Enzymes Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - pig
DOSE/DURATION :
1820 ug/kg/1Y-C
TOXIC EFFECTS :
Cardiac - arrhythmias (including changes in conduction) Cardiac - other changes
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
108 mg/kg/1Y-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Nutritional and Gross Metabolic - conditioned vitamin deficiency Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
46 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors Blood - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
15300 mg/kg/51W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1200 mg/kg
SEX/DURATION :
female 7-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
300 mg/kg
SEX/DURATION :
female 15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1190 mg/kg
SEX/DURATION :
female 16-22 day(s) after conception lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
550 mg/kg
SEX/DURATION :
female 1-22 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - behavioral
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
420 mg/kg
SEX/DURATION :
female 1-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system Reproductive - Effects on Newborn - biochemical and metabolic
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Parenteral
DOSE :
400 mg/kg
SEX/DURATION :
female 4-11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Embryo or Fetus - fetal death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Parenteral
DOSE :
800 mg/kg
SEX/DURATION :
male 2 day(s) pre-mating female 2 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Embryo or Fetus - fetal death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
100 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
300 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
80 mg/kg
SEX/DURATION :
male 3 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
90 mg/kg
SEX/DURATION :
female 6-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Effects on Embryo or Fetus - extra-embryonic structures (e.g., placenta, umbilical cord)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
1035 mg/kg
SEX/DURATION :
female 6-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
125 mg/kg
SEX/DURATION :
female 7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
250 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
250 mg/kg
SEX/DURATION :
female 7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - body wall
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
300 mg/kg
SEX/DURATION :
female 7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
848 mg/kg
SEX/DURATION :
female 60 day(s) pre-mating female 1-53 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
Sex chromosome loss and nondisjunction
TYPE OF TEST :
Morphological transformation
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Dominant lethal test
TYPE OF TEST :
Sperm Morphology
TYPE OF TEST :
Sperm Morphology

MUTATION DATA

TYPE OF TEST :
Mutation in mammalian somatic cells
TEST SYSTEM :
Rodent - hamster Lung
REFERENCE :
FCTOD7 Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.20- 1982- Volume(issue)/page/year: 23,373,1985 *** REVIEWS *** ACGIH TLV-Not classifiable as a human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 1 mg/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 12,225,1976 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 12,225,1976 IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 53,403,1991 IARC Cancer Review:Human Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 53,403,1991 IARC Cancer Review:Group 3 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 53,403,1991 TOXICOLOGY REVIEW CNDQA8 Cahiers de Nutrition et de Dietetique. (Editions Meteore, 42, rue du Louvre, 75001 Paris, France) V.1- 1966- Volume(issue)/page/year: 10(3),43,1975 *** U.S. STANDARDS AND REGULATIONS *** EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION FEREAC Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- Volume(issue)/page/year: 54,7740,1989 MSHA STANDARD-air:TWA 5 mg/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,257,1971 OSHA PEL (Gen Indu):8H TWA 5 mg/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):8H TWA 5 mg/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):8H TWA 5 mg/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Fed Cont):8H TWA 5 mg/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-AUSTRALIA:TWA 5 mg/m3 JAN 1993 OEL-AUSTRIA:TWA 5 mg/m3 JAN 1993 OEL-BELGIUM:TWA 5 mg/m3 JAN 1993 OEL-DENMARK:TWA 2 mg/m3 JAN 1993 OEL-FINLAND:TWA 5 mg/m3;STEL 10 mg/m3;Skin JAN 1993 OEL-FRANCE:TWA 5 mg/m3 JAN 1993 OEL-GERMANY:TWA 5 mg/m3 JAN 1993 OEL-THE NETHERLANDS:TWA 5 mg/m3 JAN 1993 OEL-THE PHILIPPINES:TWA 5 mg/m3 JAN 1993 OEL-POLAND:TWA 0.5 mg/m3 JAN 1993 OEL-RUSSIA:STEL 0.5 mg/m3;Skin JAN 1993 OEL-SWITZERLAND:TWA 5 mg/m3;STEL 25 mg/m3 JAN 1993 OEL-THAILAND:TWA 5 mg/m3 JAN 1993 OEL-TURKEY:TWA 5 mg/m3 JAN 1993 OEL-UNITED KINGDOM:TWA 5 mg/m3;STEL 10 mg/m3 JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO THIRAM-air:10H TWA 5 mg/m3 REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 71900 No. of Facilities: 1502 (estimated) No. of Industries: 14 No. of Occupations: 37 No. of Employees: 17330 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 71900 No. of Facilities: 2234 (estimated) No. of Industries: 23 No. of Occupations: 48 No. of Employees: 47798 (estimated) No. of Female Employees: 9520 (estimated)

符号 GHS07 GHS08 GHS09
GHS07, GHS08, GHS09
信号词 Warning
危害声明 H302 + H332-H315-H317-H319-H373-H410
警示性声明 P261-P273-P280-P304 + P340 + P312-P305 + P351 + P338-P501
个人防护装备 dust mask type N95 (US);Eyeshields;Faceshields;Gloves
危害码 (欧洲) Xn:Harmful
风险声明 (欧洲) R20/22;R36/38;R43;R48/22;R50/53
安全声明 (欧洲) S26-S36/37-S60-S61
危险品运输编码 UN 2771/2811
WGK德国 3
RTECS号 JO1400000
包装等级 III
危险类别 9
海关编码 3812100000

1、二甲基二硫代氨基甲酸钠的制备在15%的氢氧化钠溶液中,加入二硫化碳和二甲胺,搅拌下控制反应温度在40~45℃,缩合反应1h以上,当pH值为9~10时反应已完全,生成二甲基二硫代氨基甲酸钠。

137-26-8 preparation
2、促进剂TMTD的制备在缩合产物中加入10%的亚硝酸钠水溶液,搅拌溶解后,经过滤,加入到氧化反应器中,缓缓滴入硫酸,通入空气,控制温度在8℃左右,进行氧化反应,生成促进剂TMTD。促进剂TMTD在反应体系中,以固体析出。经吸滤、水洗、脱水、干燥、筛分,即得成品。
137-26-8 preparation

3.在反应釜中加入二甲胺和事先溶解在溶剂中的催化剂,在此溶剂中加入二硫化碳,加热至适宜温度,搅拌下通入氧气反应。一定时间反应完全后,经过滤、洗涤、干燥即得成品。

4.在三颈瓶中加入9g(0.2mol)二甲胺和0.23g催化剂,20℃以下搅拌,滴加18.04g(0.24mol)二硫化碳,继续搅拌后,滴加30%氢氧化钠26.8g(0.2mol),此时溶液呈淡黄绿色,除去多余二硫化碳,25~40℃滴加次氯酸钠氧化,抽样检验终点,抽滤,水洗至中性,烘干,即得成品。

海关编码 3812100000